FDA approves a CRISPR-based medicine for treatment of sickle cell disease(statnews.com)
498 points by divbzero | 215 comments
STAT News article reporting the FDA's December 2023 approval of Casgevy, the first CRISPR-based medicine, for treating sickle cell disease.